Home › Idiopathic Thrombocytopenic Purpura › Florida
Idiopathic Thrombocytopenic Purpura clinical trials in Florida
3 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in Florida.
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
- Baptist MD Anderson Cancer Center, Jacksonville
- DH Cancer Research Center LLC, Margate
- University Of Miami, Miami
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07421167A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center, Miami
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06721013Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Gnp Research, Cooper City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07104565From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.